Anna Lucsok - Zynex Chief Officer

ZYXI Stock  USD 8.32  0.03  0.36%   

Insider

Anna Lucsok is Chief Officer of Zynex Inc
Age 37
Address 9655 Maroon Circle, Englewood, CO, United States, 80112
Phone303 703 4906
Webhttps://www.zynex.com

Latest Insider Transactions

2024-08-07Disposed of 8083 shares @ 8.03View

Anna Lucsok Latest Insider Activity

Tracking and analyzing the buying and selling activities of Anna Lucsok against Zynex stock is an integral part of due diligence when investing in Zynex. Anna Lucsok insider activity provides valuable insight into whether Zynex is net buyers or sellers over its current business cycle. Note, Zynex insiders must abide by specific rules, including filing SEC forms every time they buy or sell Zynex'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Zynex Management Efficiency

The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1023 %, meaning that it created $0.1023 on every $100 dollars invested by stockholders. Zynex's management efficiency ratios could be used to measure how well Zynex manages its routine affairs as well as how well it operates its assets and liabilities. The Zynex's current Return On Tangible Assets is estimated to increase to 0.09. The Zynex's current Return On Capital Employed is estimated to increase to 0.1. As of now, Zynex's Non Current Assets Total are increasing as compared to previous years. The Zynex's current Non Currrent Assets Other is estimated to increase to about 429.4 K, while Other Assets are projected to decrease to 0.95.
Zynex Inc currently holds 76.17 M in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. Zynex Inc has a current ratio of 3.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Zynex's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kenny GardnerOwens Minor
40
Maria MartinezMcKesson
62
Holly WeissMcKesson
N/A
Dave LardyPatterson Companies
N/A
Alex CPAOwens Minor
N/A
Nancy AvilaMcKesson
57
Kevin BarryPatterson Companies
45
Robert HenkelOwens Minor
66
Tim RoganPatterson Companies
53
Deborah WeitzmanCardinal Health
59
Graham StanleyHenry Schein
N/A
Tammy GomezOwens Minor
N/A
Dean ScarboroughCardinal Health
64
Jessica MayerCardinal Health
55
Kevin EmersonMcKesson
51
Linda MantiaMcKesson
52
Tom RodgersMcKesson
49
Kevin MoranCardinal Health
N/A
Ola SnowCardinal Health
56
Frank HyfteEDAP TMS SA
N/A
Andrea FrohningPatterson Companies
54
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people. Zynex Inc (ZYXI) is traded on NASDAQ Exchange in USA. It is located in 9655 Maroon Circle, Englewood, CO, United States, 80112 and employs 1,100 people. Zynex is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Zynex Inc Leadership Team

Elected by the shareholders, the Zynex's board of directors comprises two types of representatives: Zynex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zynex. The board's role is to monitor Zynex's management team and ensure that shareholders' interests are well served. Zynex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zynex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Sandgaard, Chairman, CEO and President Principal Financial Officer and Principal Accounting Officer
Anna Lucsok, Chief Officer
Dave Anttila, Director HR
Daniel Moorhead, Chief Officer
Daniel CPA, Chief Officer
Steve Fox, Executive Sales
Chelle Burkleo, VP Sales
Donald Gregg, President Solutions
Joachim Sandgaard, Information Mang
Neil Friery, I Solutions

Zynex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zynex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.14
Revenue Per Share
5.984
Quarterly Revenue Growth
0.001
Return On Assets
0.0399
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.